SOLVYR Trademark

Trademark Overview


On Tuesday, November 9, 2021, a trademark application was filed for SOLVYR with the United States Patent and Trademark Office. The USPTO has given the SOLVYR trademark a serial number of 97115555. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, December 11, 2023. This trademark is owned by Pfizer Inc.. The SOLVYR trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment and prevention of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular and viral diseases and disorders; pharmaceutical preparations for the treatment of blood disorders, bone growth disorders, skin disorders, arthritis, cancer, hypertension, pain, stroke, obesity and diabetes; pharmaceutical preparations, namely, anti-infective preparations, medicated dermatological preparations and smoking cessation preparations; vaccines for human use; Syringes sold filled with anti-arrhythmics, anesthetics, electrolyte solutions, imaging agents or diluents
solvyr

General Information


Serial Number97115555
Word MarkSOLVYR
Filing DateTuesday, November 9, 2021
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, December 11, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 13, 2022

Trademark Statements


Goods and ServicesPharmaceutical preparations for the treatment and prevention of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular and viral diseases and disorders; pharmaceutical preparations for the treatment of blood disorders, bone growth disorders, skin disorders, arthritis, cancer, hypertension, pain, stroke, obesity and diabetes; pharmaceutical preparations, namely, anti-infective preparations, medicated dermatological preparations and smoking cessation preparations; vaccines for human use; Syringes sold filled with anti-arrhythmics, anesthetics, electrolyte solutions, imaging agents or diluents

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, November 17, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NamePfizer Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 100012192

Party NamePfizer Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10017

Trademark Events


Event DateEvent Description
Monday, December 11, 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, December 11, 2023ABANDONMENT - NO USE STATEMENT FILED
Friday, April 7, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, April 5, 2023SOU EXTENSION 1 GRANTED
Wednesday, April 5, 2023SOU EXTENSION 1 FILED
Wednesday, April 5, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, March 28, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, March 28, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, March 28, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, February 21, 2023ASSIGNED TO EXAMINER
Tuesday, November 8, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, September 13, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 13, 2022PUBLISHED FOR OPPOSITION
Wednesday, August 24, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, August 9, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, August 8, 2022ASSIGNED TO EXAMINER
Wednesday, November 17, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, November 12, 2021NEW APPLICATION ENTERED